PWAM
EGRX

Park West Asset Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-449,479
Closed -$18.8M 187
2021
Q1
$18.8M Sell
449,479
-342,121
-43% -$14.3M 0.57% 49
2020
Q4
$36.9M Buy
791,600
+155,062
+24% +$7.22M 0.76% 25
2020
Q3
$27M Sell
636,538
-483,697
-43% -$20.5M 1.05% 36
2020
Q2
$53.7M Sell
1,120,235
-114,621
-9% -$5.5M 2.66% 11
2020
Q1
$56.8M Buy
1,234,856
+62,976
+5% +$2.9M 3.86% 6
2019
Q4
$70.4M Buy
1,171,880
+78,581
+7% +$4.72M 2.96% 8
2019
Q3
$61.8M Sell
1,093,299
-206,701
-16% -$11.7M 3.01% 7
2019
Q2
$72.4M Buy
1,300,000
+254,689
+24% +$14.2M 3.01% 7
2019
Q1
$52.8M Sell
1,045,311
-4,689
-0.4% -$237K 2.32% 12
2018
Q4
$42.3M Buy
1,050,000
+308,574
+42% +$12.4M 2.09% 11
2018
Q3
$51.4M Sell
741,426
-362,130
-33% -$25.1M 1.87% 14
2018
Q2
$83.5M Buy
1,103,556
+52,282
+5% +$3.96M 3.11% 6
2018
Q1
$55.4M Buy
1,051,274
+15,000
+1% +$790K 2.47% 10
2017
Q4
$55.4M Buy
1,036,274
+128,054
+14% +$6.84M 2.52% 12
2017
Q3
$54.2M Buy
908,220
+501,557
+123% +$29.9M 3.23% 9
2017
Q2
$32.1M Sell
406,663
-81,465
-17% -$6.43M 1.78% 22
2017
Q1
$40.5M Sell
488,128
-91,625
-16% -$7.6M 2.36% 13
2016
Q4
$46M Sell
579,753
-50,000
-8% -$3.97M 3.56% 10
2016
Q3
$44.1M Hold
629,753
4.01% 9
2016
Q2
$24.4M Sell
629,753
-842,444
-57% -$32.7M 2.47% 14
2016
Q1
$59.6M Buy
1,472,197
+782,197
+113% +$31.7M 5.61% 2
2015
Q4
$61.2M Buy
690,000
+189,409
+38% +$16.8M 6.6% 1
2015
Q3
$37.1M Sell
500,591
-2,994
-0.6% -$222K 3.38% 8
2015
Q2
$40.7M Sell
503,585
-121,335
-19% -$9.81M 3.78% 7
2015
Q1
$26.2M Sell
624,920
-175,080
-22% -$7.33M 3.82% 8
2014
Q4
$12.4M Buy
800,000
+132,538
+20% +$2.05M 1.97% 19
2014
Q3
$8.44M Buy
667,462
+240,562
+56% +$3.04M 1.25% 26
2014
Q2
$6.12M Buy
426,900
+217,700
+104% +$3.12M 0.8% 34
2014
Q1
$2.67M Buy
+209,200
New +$2.67M 0.3% 52